Med. praxi. 2022;19(2):139-145 | DOI: 10.36290/med.2022.021

Pitfalls in the diagnosis of subacute or de Quervain's thyroiditis

doc. MUDr. Milan Halenka, Ph.D.
III. interní klinika - nefrologická, revmatologická, endokrinologická, FN a LF UP Olomouc

Subacute thyroiditis, also known as de Quervain's thyroiditis, is a painful inflammation of the thyroid gland. The disease is relatively rare and, despite its typical clinical symptoms, laboratory features and ultrasound findings, correct diagnosis is not always quick and easy. It often follows a previous viral infection of the upper respiratory tract. The most common first symptom is palpable and painful thyroid gland accompanied often by symptoms of hyperthyroidism. The disease should be initially distinguished from prolonged upper respiratory tract infection or other causes of thyrotoxicosis and then appropriate therapy should be started. Substantial is thorough ultrasonographic examination. In addition to elementary laboratory values, it is necessary to diagnose and monitor the effect of treatment. At the beginning of the disease, close and rapid cooperation of a general practitioner, otorhinolaryngologist, sonographer and endocrinologist is needed. The course of the disease can be difficult to predict. Treatment of severe forms requires the administration of glucocorticoids. Serious complications include early relapse with the need to prolong treatment, less often late relapses after years post initial diagnosis. Persistent hypothyroidism can develop even after successful treatment. Therefore, treatment and follow-up should be already in the hands of a specialist - an endocrinologist.

Keywords: subacute thyroiditis, ultrasonography, glucocorticoids, early relapse, late recurrence, persistent hypothyroidism.

Published: May 5, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Halenka M. Pitfalls in the diagnosis of subacute or de Quervain's thyroiditis. Med. praxi. 2022;19(2):139-145. doi: 10.36290/med.2022.021.
Download citation

References

  1. Fatourechi V, Aniszewski JP, Fatourechi GZ, et al. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab. 2003;88:2100-2105. Go to original source... Go to PubMed...
  2. Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47:725-729. Go to original source... Go to PubMed...
  3. Guideline for the diagnosis of subacute thyroiditis (acute phase): Japan Thyroid Association Guidelines. www.japanthyroid.jp/en/guidelines.
  4. Nyulassy S, Hnilica P, Buc M, et al. Subacute (de Quervain's) thyroiditis: association with HLA­‑Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab. 1977;45:270-274. Go to original source... Go to PubMed...
  5. Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5. Go to original source... Go to PubMed...
  6. Martino E, Buratti L, Bartalena L, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest. 1987;10:321-323. Go to original source... Go to PubMed...
  7. Park SY, Kim EK, Kim MJ, et al. Ultrasonographic characteristics of subacute granulomatous thyroiditis. Korean J Radiol. 2006;7:229-234. Go to original source... Go to PubMed...
  8. Mizukoshi T, Noguchi S, Murakami T, et al. Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone. Intern Med. 2001;40:292-295. Go to original source... Go to PubMed...
  9. Arao T, Okada Y, Torimoto K, et al. Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis. J UOEH. 2015;37: 103-110. Go to original source... Go to PubMed...
  10. Nishihara E, Hirokawa M, Ohye H, et al. Papillary carcinoma obscured by complication with subacute thyroiditis: sequential ultrasonographic and histopathological findings in five cases. Thyroid. 2008;18:1221-1225. Go to original source... Go to PubMed...
  11. Iitaka M, Momotani N, Ishii J, et al. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab. 1996;81: 466-469. Go to original source...
  12. Nishihara E, Amino N, Ohye H, et al. Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis. J Endocrinol Invest. 2009;32:33-36. Go to original source... Go to PubMed...
  13. Sato J, Uchida T, Komiya K, et al. Comparison of the therapeutic effects of prednisolone and nonsteroidal anti­‑inflammatory drugs in patients with subacute thyroiditis. Endocrine. 2017;55:209-214. Go to original source... Go to PubMed...
  14. Halenka M, Schovánek J, Fryšák Z, Karásek D. Subakutní neboli de Quervainova tyreoiditida, "nemoc, na kterou jsme zapomněli" (část II. - vlastní soubor). Interní Med. 2019;21:233-237. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.